Sun Pharma signs Definitive Agreement to Acquire Organon

Organon stockholders to receive US$ 14.00 per share in cash The deal values Organon at EV of US$ 11.75 billion Combined Business leverages complementary portfolios and global scale for sustained long‑term value creation MUMBAI, India & JERSEY CITY, N.J.–(BUSINESS WIRE)–Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its … [Read more…]

Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss

Conference call will take place on Monday, April 27, 2026 at 8:00 am ET NEW HAVEN, Conn.–(BUSINESS WIRE)–Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced it will host an investor call and live webcast to review topline results from Part A of its … [Read more…]

Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System

84% Freedom From Shock and 59% Freedom From VT Recurrence in FULCRUM-VT Pivotal IDE Trial Meet Safety and Effectiveness Endpoints and Replicate CryoCure-VT Results First and Only Ablation Technology to Show Equivalent Effectiveness Across Ischemic and Non-Ischemic Cardiomyopathy All From Endocardial Approach LAGUNA HILLS, Calif.–(BUSINESS WIRE)–$ADGM #Arrhythmia–Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the … [Read more…]

Rich Eisen Brings Iconic ‘Run Rich Run’ 40-Yard Dash to St. Jude Children’s Research Hospital

For the first time, Eisen and NFL Network filmed on the St. Jude campus alongside patient families, staff and supporters, surrounded by the research hospital that his fundraising helps support MEMPHIS, Tenn.–(BUSINESS WIRE)–Rich Eisen, one of the most recognizable voices in sports media, brought his iconic “Run Rich Run” 40-yard dash to the campus of … [Read more…]

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026

Multicenter results show sustained high durability and procedural efficiency, redefining positive expectations for catheter ablation in patients with atrial fibrillation HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced late-breaking positive clinical data from its nPulse Cardiac Catheter System … [Read more…]

Integrant announces closure of Series A capital raise. Now exploring pre-IPO raise ahead of November listing

SYDNEY–(BUSINESS WIRE)–#AI–Integrant (proposed ticker: INGT) today announced the successful closure of its Series A capital raise, originally opened in April 2025. The round attracted strong investor interest, with responses described by the company as highly encouraging and reflective of growing confidence in its technology and strategic direction. Since initiating the Series A, Integrant has achieved … [Read more…]

Leukemia Survivors to Meet Their Lifesaving Stem Cell Donors at City of Hope’s Annual Bone Marrow Transplant (BMT) Reunion, Celebrating Program’s 50-Year Milestone

Los Angeles high school senior Vaughn Wilson and two-time cancer survivor Lynn Leiro of Alhambra, California, will meet their unrelated donors for the first time at City of Hope’s annual BMT Reunion on Friday, May 1, on the Duarte campus. The reunion marks the 50th anniversary of City of Hope’s BMT program – one of … [Read more…]

Fertility Specialists of Texas and First Fertility Highlight Scientific Leadership at ASPIRE 2026

PLANO, Texas–(BUSINESS WIRE)–Fertility Specialists of Texas and First Fertility, leading providers of advanced reproductive care focused on personalized, patient-centered treatment, announce new research presented by Dr. Carlos Guerrero at the ASPIRE Conference 2026—work that reflects both scientific rigor and meaningful impact in reproductive medicine. Advancing science. Expanding possibility. Redefining what we understand about fertility. Dr. … [Read more…]

Transcarent Expands WayFinding™ Platform with SmithRx to Offer More Options for Pharmacy Pricing Transparency and Lower Drug Costs to Employers

AI-powered real-time information and guidance provides health consumers a better experience, a more inclusive pharmacy network and access to lower cost medications SAN FRANCISCO–(BUSINESS WIRE)–#HealthWayFinding—Transcarent, the One Place for Health and Care™, today announced an expansion of its Pharmacy Care Experience with the addition of SmithRx, a next-generation pharmacy benefits management (PBM) company, as its … [Read more…]

The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc.

Proposal Provides Stockholders $2.35 per Share in Cash, a 39% Premium to the Unaffected Closing Price, as Well as Potential Additional Value from the Sale of Seer’s Assets via a Contingent Value Right Proposal Provides Stockholders Immediate and Significant Value While Avoiding Further Value Destruction from Continued Abysmal Operating Results Criticizes the Board for Failing … [Read more…]